This document discusses the validity and legality of pre-employment medical screening, specifically focusing on drug testing. It outlines the history of pre-employment physical exams and increasing concerns around privacy as medical data becomes digitized. Validity of drug screening tests is also examined, noting many legal prescribed medications can cause false positives for illicit drugs due to cross-reactivity. The document argues employers should use more specific confirmatory tests and consider factors like prescribed medications and food items that could impact screening results to avoid potential discrimination during hiring.
The document discusses the key stages in the drug discovery and development process including target selection, compound screening and hit optimization, selecting a drug candidate through further optimization of properties like absorption and metabolism, safety testing in animals and humans, proof of concept clinical trials in patients, large phase 3 clinical trials for registration and approval, and finally launch and life cycle management. It notes that the entire process from discovery to approval can take 12-16 years and cost over $1 billion.
Abbott pharma marketing survey to know presciption pattern among the dermatol...shahwaz9898
This document summarizes a study on the prescription patterns of dermatologists for hyperpigmentation drugs in Delhi, India. The study collected primary data through questionnaires with 80 dermatologists in South Delhi. It found that the most commonly prescribed drugs were kojic acid (47.5%) and hydroquinone (21.2%), and the most common type of hyperpigmentation was melasma. Most patients saw improvements after 3-6 months of treatment. Common side effects included itching, hypopigmentation, and atrophy. Limitations of the study included its limited area and sample size.
Overcoming challenges in Drug DevelopmentCharles Oo
This document outlines strategies for overcoming challenges in drug development. It discusses the current long and expensive drug development process, as well as growing regulatory hurdles. It argues that innovation is needed, including open innovation models, a shift to personalized medicine, balancing drug toxicity and safety, leveraging technological advances like biomarkers, and using adaptive clinical trial designs. The key message is that new approaches are required to reduce costs, cycle times, and failure rates in drug development.
Seriously Ill Patients Access To Experimental TherapiesRyan Witt
There are four main methods for terminally or seriously ill patients to access experimental therapies: clinical trials, expanded access programs, compassionate use protocols, and emergency use. However, few patients enroll in clinical trials or access experimental therapies through other means due to various barriers. These barriers include lack of awareness about opportunities, concerns from drug companies about liability and bad publicity, limitations on access to early-stage experimental therapies, and lack of incentives for drug companies to provide access. Efforts are needed to help more patients learn about and navigate options to access potentially life-saving experimental treatments.
stages of the medication use process and medication errorsMEEQAT HOSPITAL
This document discusses stages of the medication use process and medication errors. It describes the five stages where errors can occur: physician ordering, transcribing orders, dispensing, administration, and monitoring. Errors commonly happen during ordering and administration. Types of errors include wrong dose, duration, medication, frequency and drug interactions. Adverse drug events can be preventable due to errors or non-preventable reactions. The document provides examples of errors like prescribing a contraindicated drug and scenarios to classify error types. It emphasizes learning from errors to enhance patient safety.
Clinical research and its importance career in clinical researchRidhimaPatel2
This document is expressing the carrier opportunities in clinical research and how it important to learn clinical research for our society and the best institute providing absolute best training for the clinical research
Medication errors are preventable events that can harm patients. This presentation discussed medication errors, including classifications, types, causes, and strategies to prevent them. It summarized key points about prescribing errors, dispensing errors, administration errors, and monitoring errors. The presentation emphasized the importance of following proper procedures, such as double checking orders and medications, reconciling medications, and educating staff on policies to minimize errors. Overall, the presentation aimed to increase awareness of medication errors and promote safe practices to protect patients.
Clinical trials involve testing investigational drugs or treatments on human subjects to determine safety and efficacy. They progress through several phases, beginning with small pre-clinical trials on animals. Phase 1 trials involve 20-50 healthy volunteers to assess pharmacokinetics and safety. Phase 2 trials enroll 50-300 patient volunteers to further evaluate safety and dosage. Phase 3 trials are large randomized controlled trials of 250-1000+ subjects comparing the investigational treatment to standard treatment or placebo. If Phase 3 is successful, the results are submitted to regulatory agencies for approval to market the new drug. Post-marketing Phase 4 trials monitor long-term safety and efficacy.
The document discusses the key stages in the drug discovery and development process including target selection, compound screening and hit optimization, selecting a drug candidate through further optimization of properties like absorption and metabolism, safety testing in animals and humans, proof of concept clinical trials in patients, large phase 3 clinical trials for registration and approval, and finally launch and life cycle management. It notes that the entire process from discovery to approval can take 12-16 years and cost over $1 billion.
Abbott pharma marketing survey to know presciption pattern among the dermatol...shahwaz9898
This document summarizes a study on the prescription patterns of dermatologists for hyperpigmentation drugs in Delhi, India. The study collected primary data through questionnaires with 80 dermatologists in South Delhi. It found that the most commonly prescribed drugs were kojic acid (47.5%) and hydroquinone (21.2%), and the most common type of hyperpigmentation was melasma. Most patients saw improvements after 3-6 months of treatment. Common side effects included itching, hypopigmentation, and atrophy. Limitations of the study included its limited area and sample size.
Overcoming challenges in Drug DevelopmentCharles Oo
This document outlines strategies for overcoming challenges in drug development. It discusses the current long and expensive drug development process, as well as growing regulatory hurdles. It argues that innovation is needed, including open innovation models, a shift to personalized medicine, balancing drug toxicity and safety, leveraging technological advances like biomarkers, and using adaptive clinical trial designs. The key message is that new approaches are required to reduce costs, cycle times, and failure rates in drug development.
Seriously Ill Patients Access To Experimental TherapiesRyan Witt
There are four main methods for terminally or seriously ill patients to access experimental therapies: clinical trials, expanded access programs, compassionate use protocols, and emergency use. However, few patients enroll in clinical trials or access experimental therapies through other means due to various barriers. These barriers include lack of awareness about opportunities, concerns from drug companies about liability and bad publicity, limitations on access to early-stage experimental therapies, and lack of incentives for drug companies to provide access. Efforts are needed to help more patients learn about and navigate options to access potentially life-saving experimental treatments.
stages of the medication use process and medication errorsMEEQAT HOSPITAL
This document discusses stages of the medication use process and medication errors. It describes the five stages where errors can occur: physician ordering, transcribing orders, dispensing, administration, and monitoring. Errors commonly happen during ordering and administration. Types of errors include wrong dose, duration, medication, frequency and drug interactions. Adverse drug events can be preventable due to errors or non-preventable reactions. The document provides examples of errors like prescribing a contraindicated drug and scenarios to classify error types. It emphasizes learning from errors to enhance patient safety.
Clinical research and its importance career in clinical researchRidhimaPatel2
This document is expressing the carrier opportunities in clinical research and how it important to learn clinical research for our society and the best institute providing absolute best training for the clinical research
Medication errors are preventable events that can harm patients. This presentation discussed medication errors, including classifications, types, causes, and strategies to prevent them. It summarized key points about prescribing errors, dispensing errors, administration errors, and monitoring errors. The presentation emphasized the importance of following proper procedures, such as double checking orders and medications, reconciling medications, and educating staff on policies to minimize errors. Overall, the presentation aimed to increase awareness of medication errors and promote safe practices to protect patients.
Clinical trials involve testing investigational drugs or treatments on human subjects to determine safety and efficacy. They progress through several phases, beginning with small pre-clinical trials on animals. Phase 1 trials involve 20-50 healthy volunteers to assess pharmacokinetics and safety. Phase 2 trials enroll 50-300 patient volunteers to further evaluate safety and dosage. Phase 3 trials are large randomized controlled trials of 250-1000+ subjects comparing the investigational treatment to standard treatment or placebo. If Phase 3 is successful, the results are submitted to regulatory agencies for approval to market the new drug. Post-marketing Phase 4 trials monitor long-term safety and efficacy.
Pakistan's Regulatory Approach: Can Quality of Drug be assured through Testin...Obaid Ali / Roohi B. Obaid
Disclaimer: It is purely personal point of view written in the best of professional knowledge and experience of dealing with affairs of regulatory sciences as Federal Regulator. In any way, it is not an obligation to agree by the organization or association to which we belong. The intent of writing is to sensitize culture of reading, learning, arguing and writing. Feedback: All critics, comments and questions will be welcome
Medication errors can occur during prescribing, dispensing, or administration of drugs and include errors like using the wrong drug, wrong dose, or wrong route of administration. Common causes of errors include illegible handwriting, look-alike or sound-alike drug names, distractions, and lack of concentration. Types of errors include prescribing errors, dispensing errors, and administration errors. Reducing errors requires strategies like electronic prescribing, minimizing interruptions during drug administration, verifying patient identity, and ensuring the right drug is given to the right patient at the right time. When errors occur, they must be reported so the safety of the patient can be ensured and steps can be taken to prevent future errors.
Drug Utilization in a regulated EnviormentAlok Anand
Tracking drugs across the supply chain in a regulated environment. This white paper brief on would be drug utilization approach of Life Science Industry. This white paper is just a step forward to show future life science industry process automation
Direct to consumer genetic testing provides ancestry and health risk information directly to consumers but has significant limitations. While it may promote health awareness, unexpected results can be stressful and consumers may make important medical decisions based on inaccurate or incomplete information from unregulated tests. The high rate of false positives seen in confirmatory testing suggests many consumers are receiving incorrect information from these tests. Regulatory bodies have concerns about oversight, accuracy, and inappropriate use of genetic data that could impact consumers.
The document discusses medication errors, including common types, causes, and strategies for prevention. It notes that medication errors are a serious issue, causing up to 98,000 deaths per year. Errors can occur at any step in the medication process and are often due to human factors like poor communication or illegible handwriting, as well as system factors like confusing drug names. Strategies to reduce errors include using clear verbal order protocols, limiting dangerous abbreviations, implementing computerized physician order entry and barcoding, and having a just culture approach that supports healthcare workers involved in errors.
This document provides an overview of using gene expression profiling to evaluate drug metabolism-induced toxicity. It discusses how drug metabolism can lead to toxicity and the need to systematically evaluate this in pre-clinical studies. It then describes using Qiagen's RT2 Profiler PCR Arrays, which allow profiling of 84 drug metabolizing enzyme genes, to detect abnormalities in drug metabolism and identify mechanisms of toxicity using human hepatocytes treated with different compounds as an example application. The results showed induction and inhibition of various metabolizing enzyme genes in response to the compounds tested.
This document discusses medication errors, including definitions, types, causes, and ways to improve safety. Some key points:
- Medication errors are preventable events that may harm patients and are caused by failures in prescribing, dispensing, administration, or monitoring.
- Errors can occur at various stages of the medication use process and be due to factors like high workload, look-alike drug names, and poor communication.
- High-risk medications like anticoagulants require special precautions. Healthcare professionals should know drugs well, use memory aids, and develop checking habits to minimize errors.
- Encouraging patient involvement, thorough documentation, learning from past errors, and clear communication can also
Toxicological Approach to Drug DiscoverySuhas Reddy C
This document outlines the toxicological approach to drug development. It discusses the importance of conducting various toxicity studies at different stages of drug development to ensure safety. These include single dose, repeated dose, fertility, reproductive, developmental and genotoxicity studies in animals. It describes the typical safety program involving staged approach and discusses factors to consider in designing toxicity studies. The goal is to obtain sufficient non-clinical safety data to support clinical trials and assess safety for human use.
The document discusses medication errors, which are preventable failures in the treatment process that can harm patients. It defines medication errors and classifies them by cause, stage of occurrence, and severity of harm. Prescribing errors are the most common, followed by administration and dispensing errors. Technologies like computerized prescribing and barcoding can reduce errors but implementing them faces challenges. Improving handwritten prescription quality, such as using standard formats and avoiding ambiguous abbreviations, also aims to reduce errors. The conclusion emphasizes that both technological solutions and improving manual processes are needed to enhance patient safety by reducing medication errors.
Preclinical Development, Introduction
Definition, Stages of development of a new drug, Objectives of Preclinical studies, Several steps in preclinical trials, Types of studies in Preclinical trials, Importance of preclinical trials
By
Ms. I. Sai Reddemma.
Department of Pharmacology
Speaker: Wendy Hill, Gap Strategies. Part of the MaRS Best Practices Series.This session, led by seasoned industry experts, will explore how to effectively set up your pre-clinical POC studies, address pre-clinical safety requirements and issues, and give you an overview of the manufacturing standards required for Phase I studies
More information: http://www.marsdd.com/Events/Event-Calendar/Best-Practices-Series/ind-05132008.html
Pre-clinical trials involve testing new drugs, procedures, or medical treatments in animals before beginning clinical trials in humans. They aim to determine safety and efficacy. The document outlines the stages of pre-clinical trials including in vitro and in vivo testing, pharmacokinetic studies, toxicity tests, and FDA review requirements. The goals are to identify safe starting doses in humans, target organs for toxicity, and safety parameters for clinical monitoring before human trials.
Drug Discovery, Development & Clinical trials: Current status and the way...JEETU GANGIL
India has become a top destination for clinical drug trials due to its large patient population, lower costs compared to Western countries, and adherence to international standards. The Indian pharmaceutical market is expected to triple in size to $20 billion by 2015, making it one of the top 10 markets globally. However, India faces some challenges like increasing its regulatory reputation and infrastructure to fully capitalize on the growing clinical research industry.
This document provides an overview of liabilities facing pharmacists, including pharmacy robberies, criminal liability, civil liability, issues with CMS (Centers for Medicare and Medicaid Services), and board investigations. It discusses the risks of pharmacy robberies, such as psychological impact on employees, loss of employees and business, and time/expense of investigations. It also covers the corresponding responsibility doctrine, which establishes that pharmacists have an obligation to only fill prescriptions that are issued properly for legitimate medical treatment. Case law examples demonstrate that pharmacists can be held criminally liable for filling improper prescriptions, especially those involving controlled substances, if they knew or should have known the prescription was not valid.
This document provides career advice for those seeking positions in pharmacoepidemiology. It discusses the skills and qualifications desired by hiring managers, including strong methodological and statistical analysis skills, expertise in at least one therapeutic area, and the ability to manage large datasets. It also outlines the range of responsibilities that epidemiologists may have in industry, from contributing to disease understanding and drug development to post-approval safety studies.
Adverse Event Monitoring
• Identify relationships between drugs, diseases and devices and their associated events
• Use new filter options to search, visualize and export drug, device and disease-specific details
• Learn how new query language possibilities enable identification of specific drug- or device-related adverse events
The document discusses medication errors, including their definition, causes, and stages. Medication errors can occur at several points including ordering, dispensing, administration, and monitoring. They may be caused by issues like poor communication, look-alike or sound-alike drug names, distractions, and fatigue. To reduce errors, the document recommends always double checking medications against the 5 rights and not assuming others have already caught any mistakes.
Being a pharmacist takes about 6 years of schooling and involves advising patients and doctors on medications. While the job offers security, respect, and a good salary, it also involves shift work and high liability. Mistakes in filling prescriptions can harm patients and result in lawsuits. Some drug companies also refuse to make certain medications affordable for low-income patients, putting many lives at risk. Overall, being a pharmacist is rewarding but also comes with challenges in ensuring medications are properly administered and widely accessible.
La subjetividad define la personalidad y las emociones de una persona. Un bebé recién nacido no distingue entre la madre y el universo, sino que los ve como un todo. Existen diferentes tipos de subjetividad: intrasubjetividad (cuestiones personales no negociables), intersubjetividad (intercambio con otros que se puede elegir) y transsubjetividad (normas definidas a nivel social más amplio y negociadas tácitamente).
Pakistan's Regulatory Approach: Can Quality of Drug be assured through Testin...Obaid Ali / Roohi B. Obaid
Disclaimer: It is purely personal point of view written in the best of professional knowledge and experience of dealing with affairs of regulatory sciences as Federal Regulator. In any way, it is not an obligation to agree by the organization or association to which we belong. The intent of writing is to sensitize culture of reading, learning, arguing and writing. Feedback: All critics, comments and questions will be welcome
Medication errors can occur during prescribing, dispensing, or administration of drugs and include errors like using the wrong drug, wrong dose, or wrong route of administration. Common causes of errors include illegible handwriting, look-alike or sound-alike drug names, distractions, and lack of concentration. Types of errors include prescribing errors, dispensing errors, and administration errors. Reducing errors requires strategies like electronic prescribing, minimizing interruptions during drug administration, verifying patient identity, and ensuring the right drug is given to the right patient at the right time. When errors occur, they must be reported so the safety of the patient can be ensured and steps can be taken to prevent future errors.
Drug Utilization in a regulated EnviormentAlok Anand
Tracking drugs across the supply chain in a regulated environment. This white paper brief on would be drug utilization approach of Life Science Industry. This white paper is just a step forward to show future life science industry process automation
Direct to consumer genetic testing provides ancestry and health risk information directly to consumers but has significant limitations. While it may promote health awareness, unexpected results can be stressful and consumers may make important medical decisions based on inaccurate or incomplete information from unregulated tests. The high rate of false positives seen in confirmatory testing suggests many consumers are receiving incorrect information from these tests. Regulatory bodies have concerns about oversight, accuracy, and inappropriate use of genetic data that could impact consumers.
The document discusses medication errors, including common types, causes, and strategies for prevention. It notes that medication errors are a serious issue, causing up to 98,000 deaths per year. Errors can occur at any step in the medication process and are often due to human factors like poor communication or illegible handwriting, as well as system factors like confusing drug names. Strategies to reduce errors include using clear verbal order protocols, limiting dangerous abbreviations, implementing computerized physician order entry and barcoding, and having a just culture approach that supports healthcare workers involved in errors.
This document provides an overview of using gene expression profiling to evaluate drug metabolism-induced toxicity. It discusses how drug metabolism can lead to toxicity and the need to systematically evaluate this in pre-clinical studies. It then describes using Qiagen's RT2 Profiler PCR Arrays, which allow profiling of 84 drug metabolizing enzyme genes, to detect abnormalities in drug metabolism and identify mechanisms of toxicity using human hepatocytes treated with different compounds as an example application. The results showed induction and inhibition of various metabolizing enzyme genes in response to the compounds tested.
This document discusses medication errors, including definitions, types, causes, and ways to improve safety. Some key points:
- Medication errors are preventable events that may harm patients and are caused by failures in prescribing, dispensing, administration, or monitoring.
- Errors can occur at various stages of the medication use process and be due to factors like high workload, look-alike drug names, and poor communication.
- High-risk medications like anticoagulants require special precautions. Healthcare professionals should know drugs well, use memory aids, and develop checking habits to minimize errors.
- Encouraging patient involvement, thorough documentation, learning from past errors, and clear communication can also
Toxicological Approach to Drug DiscoverySuhas Reddy C
This document outlines the toxicological approach to drug development. It discusses the importance of conducting various toxicity studies at different stages of drug development to ensure safety. These include single dose, repeated dose, fertility, reproductive, developmental and genotoxicity studies in animals. It describes the typical safety program involving staged approach and discusses factors to consider in designing toxicity studies. The goal is to obtain sufficient non-clinical safety data to support clinical trials and assess safety for human use.
The document discusses medication errors, which are preventable failures in the treatment process that can harm patients. It defines medication errors and classifies them by cause, stage of occurrence, and severity of harm. Prescribing errors are the most common, followed by administration and dispensing errors. Technologies like computerized prescribing and barcoding can reduce errors but implementing them faces challenges. Improving handwritten prescription quality, such as using standard formats and avoiding ambiguous abbreviations, also aims to reduce errors. The conclusion emphasizes that both technological solutions and improving manual processes are needed to enhance patient safety by reducing medication errors.
Preclinical Development, Introduction
Definition, Stages of development of a new drug, Objectives of Preclinical studies, Several steps in preclinical trials, Types of studies in Preclinical trials, Importance of preclinical trials
By
Ms. I. Sai Reddemma.
Department of Pharmacology
Speaker: Wendy Hill, Gap Strategies. Part of the MaRS Best Practices Series.This session, led by seasoned industry experts, will explore how to effectively set up your pre-clinical POC studies, address pre-clinical safety requirements and issues, and give you an overview of the manufacturing standards required for Phase I studies
More information: http://www.marsdd.com/Events/Event-Calendar/Best-Practices-Series/ind-05132008.html
Pre-clinical trials involve testing new drugs, procedures, or medical treatments in animals before beginning clinical trials in humans. They aim to determine safety and efficacy. The document outlines the stages of pre-clinical trials including in vitro and in vivo testing, pharmacokinetic studies, toxicity tests, and FDA review requirements. The goals are to identify safe starting doses in humans, target organs for toxicity, and safety parameters for clinical monitoring before human trials.
Drug Discovery, Development & Clinical trials: Current status and the way...JEETU GANGIL
India has become a top destination for clinical drug trials due to its large patient population, lower costs compared to Western countries, and adherence to international standards. The Indian pharmaceutical market is expected to triple in size to $20 billion by 2015, making it one of the top 10 markets globally. However, India faces some challenges like increasing its regulatory reputation and infrastructure to fully capitalize on the growing clinical research industry.
This document provides an overview of liabilities facing pharmacists, including pharmacy robberies, criminal liability, civil liability, issues with CMS (Centers for Medicare and Medicaid Services), and board investigations. It discusses the risks of pharmacy robberies, such as psychological impact on employees, loss of employees and business, and time/expense of investigations. It also covers the corresponding responsibility doctrine, which establishes that pharmacists have an obligation to only fill prescriptions that are issued properly for legitimate medical treatment. Case law examples demonstrate that pharmacists can be held criminally liable for filling improper prescriptions, especially those involving controlled substances, if they knew or should have known the prescription was not valid.
This document provides career advice for those seeking positions in pharmacoepidemiology. It discusses the skills and qualifications desired by hiring managers, including strong methodological and statistical analysis skills, expertise in at least one therapeutic area, and the ability to manage large datasets. It also outlines the range of responsibilities that epidemiologists may have in industry, from contributing to disease understanding and drug development to post-approval safety studies.
Adverse Event Monitoring
• Identify relationships between drugs, diseases and devices and their associated events
• Use new filter options to search, visualize and export drug, device and disease-specific details
• Learn how new query language possibilities enable identification of specific drug- or device-related adverse events
The document discusses medication errors, including their definition, causes, and stages. Medication errors can occur at several points including ordering, dispensing, administration, and monitoring. They may be caused by issues like poor communication, look-alike or sound-alike drug names, distractions, and fatigue. To reduce errors, the document recommends always double checking medications against the 5 rights and not assuming others have already caught any mistakes.
Being a pharmacist takes about 6 years of schooling and involves advising patients and doctors on medications. While the job offers security, respect, and a good salary, it also involves shift work and high liability. Mistakes in filling prescriptions can harm patients and result in lawsuits. Some drug companies also refuse to make certain medications affordable for low-income patients, putting many lives at risk. Overall, being a pharmacist is rewarding but also comes with challenges in ensuring medications are properly administered and widely accessible.
La subjetividad define la personalidad y las emociones de una persona. Un bebé recién nacido no distingue entre la madre y el universo, sino que los ve como un todo. Existen diferentes tipos de subjetividad: intrasubjetividad (cuestiones personales no negociables), intersubjetividad (intercambio con otros que se puede elegir) y transsubjetividad (normas definidas a nivel social más amplio y negociadas tácitamente).
El documento describe los nuevos roles del profesorado y el alumnado en entornos educativos mediados por las tecnologías de la información y la comunicación (TIC). Para los profesores, los nuevos roles incluyen ser facilitador, orientador, tutor virtual, moderador, consultor de información, evaluador continuo y diseñador de materiales educativos. Para los estudiantes, los nuevos roles requieren ser más activos, tomar iniciativas, aprender de manera independiente, aplicar conocimientos a nuevas situaciones y desarrollar habilidades como la comunic
Formaciones académica e imaginarios profesionales del comunicador yUNSA
Este documento discute diferentes formaciones y roles profesionales para comunicadores, incluyendo periodistas, comunicólogos e intelectuales críticos. También explora cómo la comunicación puede contribuir a la construcción social a través de fortalecer relaciones, generar debates públicos y promover demandas sociales. El comunicador tiene un compromiso de compartir conocimientos y habilidades con la gente de manera recíproca, con el objetivo de promover cambios.
Este documento presenta los resultados de una encuesta realizada en una institución escolar. La encuesta buscaba identificar las herramientas y artefactos culturales utilizados para la comunicación, socialización de información y desarrollo personal. Las preguntas se centraron en los recursos de búsqueda de información, las tecnologías disponibles en la escuela y las herramientas de comunicación. Las respuestas de los estudiantes y profesores mostraron diferencias en el uso de la tecnología, posiblemente debido a que los estudiantes
Este documento trata sobre la ideología e imaginarios sociales. Define la ideología como un conjunto de valores, creencias e instituciones que dan sentido al mundo. Explica que todas las sociedades tienen una ideología dominante compartida por la mayoría que apoya los intereses de la clase dominante. También describe los aparatos represivos e ideológicos del estado que obligan a aceptar la ideología dominante o socializan a través de instituciones como la familia y la educación. Finalmente, define los imaginarios sociales como conjuntos de imágenes mentales
Programa de Profesionalización Docente - ULA/ FACULTAD DE HUMANIDADES Y EDUCACIÓN- PONENTES: Abg. Daniela Vita, Abg. Rosario Ramos, Lic. Keyla Pérez y Lic. Luzcelvy Rodríguez.
Este documento presenta la línea de investigación del programa de Psicología en la UNAD llamada "Psicología y construcción de subjetividades". El objetivo general es abordar las dinámicas de la subjetividad desde una perspectiva bio-psico-social y cultural. Se proponen cinco sublíneas de investigación relacionadas con la construcción de subjetividades en contextos educativos, comunitarios, familiares y sobre sujetos de la marginalidad y derecho. Las actividades del curso de diseño de proyectos sociales estarán alineadas
Diferencias entre la integración y la inclusión educativa.Sonia Cano
La integración educativa implica que los estudiantes con discapacidades se adaptan a la comunidad educativa existente, mientras que la inclusión educativa implica el derecho de todos los estudiantes a estar en aulas regulares y alcanzar el éxito escolar a través de una educación que satisface las necesidades de diversos estudiantes. Además, la educación inclusiva es un derecho humano que genera una sociedad más consciente e igualitaria.
Pablo Pineda, la primera persona con síndrome de Down en obtener un título universitario en Europa, se ha licenciado en magisterio y está cerca de obtener una segunda titulación. Además de su éxito académico, Pineda trabajó como actor y su próximo objetivo es sacar su licencia de conducir para ser un ejemplo de independencia para otras personas con síndrome de Down. En una entrevista, Pineda enfatizó la importancia de confiar en las capacidades de las personas con discapacidades y estimularlas sin límites
El documento describe la estructura del sistema educativo nacional, incluyendo sus niveles (inicial, primaria, secundaria, superior), modalidades (de menores, adultos, especial, ocupacional, a distancia) y objetivos. Explica conceptos clave como objetivos educativos, competencias y contenidos de aprendizaje (conceptuales, procedimentales, actitudinales).
El documento describe cómo la subjetividad se configura y desarrolla a través de las relaciones sociales y vínculos. La vida cotidiana emerge de las necesidades de los individuos en el contexto de las estructuras sociales, y áreas como la familia, el trabajo y el tiempo libre configuran la subjetividad. El documento también analiza cómo la desnutrición sigue siendo un problema que afecta a miles de niños en Tucumán, Argentina.
El documento describe el concepto de "orden socio-histórico" y por qué es importante en psicología social. Explica que el orden socio-histórico se refiere a la estructura y organización de la sociedad, incluidas las relaciones, instituciones y formas de pensamiento, que están en constante cambio y evolución. También describe cómo el orden socio-histórico moldea la subjetividad humana a través de procesos como la comunicación, el aprendizaje y la identificación. Finalmente, señala que la psicología social
Este documento presenta una introducción a la sociología de la educación. Define la sociología como el estudio sistemático de los grupos y las sociedades, y explica que la sociología de la educación analiza cómo el sistema educativo emerge de y actúa sobre la sociedad, examinando conceptos como la socialización, las funciones de la educación, y las relaciones entre la escuela y otros sistemas sociales. Finalmente, introduce algunos conceptos sociológicos clave relacionados con la educación.
Este documento describe las técnicas sociométricas para analizar las relaciones en grupos, incluyendo el test sociométrico y su proceso de construcción. Explica que el test sociométrico permite estudiar las preferencias y rechazos entre miembros de un grupo a través de preguntas. Luego, las respuestas se analizan cuantitativamente usando una matriz sociométrica y valores como el estatus sociométrico de cada persona. El objetivo es mapear la estructura informal del grupo.
Autor:JORGE RODRIGO CASTILLO ROMERO
"Se entiende por “humanismo” toda cultura que pueda rebasar los límites de un pueblo adquiriendo carácter universal y, por tanto, toda enseñanza que tienda a hacer a los seres humanos más “humanos” y a acentuar lo esencial por encima de lo contingente, el sentido de humanidad sobre el de nación o región. Así, pues, el humanismo tanto más rico tanto mayor es la facultad de crear valores de atracción e influencia universales, depende menos de la materia o materias que se hagan estudiar que del modo de enseñarlas y por tanto, del ideal humanista del educador, que sabrá extraer de cualquier materia de enseñanza, el contenido humano del que se hallan cargados." Fernando de Acevedo.
Métodos de evaluación. técnicas e instrumentoselvia72
El documento presenta información sobre la evaluación institucional en un programa de maestría. Describe diferentes técnicas e instrumentos de evaluación como observaciones, listas de cotejo, escalas de estimación, registros anecdóticos, cuestionarios, entrevistas y pruebas. Explica que la evaluación puede medir procesos, productos y resultados, y utilizar métodos cuantitativos y cualitativos. El objetivo principal es mejorar continuamente los procesos educativos.
El desarrollo de la sociología de la Educación . Principales Enfoques o Escue...Elis Vergara
Este documento resume las principales escuelas y enfoques de la sociología de la educación, incluyendo autores clásicos como Comte, Marx y Durkheim, así como teorías posteriores como la reproducción, el habitus, la correspondencia y las teorías dialógicas y comunicativas más recientes. Cubre conceptos y aportes clave de cada autor o escuela al desarrollo del campo.
Safety pharmacology seeks to predict if a drug administered to humans would be unsafe. Prior to 1990, companies conducted toxicological testing during drug discovery. In the 1990s, the antihistamine terfenadine was withdrawn due to its potential for life-threatening cardiac side effects. This led to increased efforts by industry and regulators through initiatives like the International Conference on Harmonisation to improve safety testing and accommodate regulatory requirements. Safety pharmacology testing helps determine potential undesirable effects on body systems and inform decisions on advancing to human testing or discontinuing development, with the goal of identifying unsafe drugs early.
The document provides an overview of clinical trials and the drug development process. It discusses the importance of clinical trials in translating basic research into new treatments. There are different types of clinical trials such as treatment, prevention, and diagnostic trials. The drug development process involves drug discovery, pre-clinical animal testing, and 4 phases of clinical trials in humans to test safety, efficacy, and get regulatory approval. Phase 1 trials involve few participants to test safety, while Phase 2 and 3 trials have larger numbers of participants to further evaluate safety and efficacy. Phase 4 trials monitor safety after market approval. Randomization and blinding are important trial design elements to reduce bias.
Pre-clinical and clinical trials are processes used to test drugs and medical devices for safety and efficacy before human use. Pre-clinical trials involve basic research and testing in animals. If promising, an Investigational New Drug application is filed with the FDA to begin clinical trials with humans. Clinical trials are conducted in phases, starting with small safety trials and progressing to large efficacy trials. If successful, final approval is sought from the FDA through a New Drug Application. The entire drug development process from basic research to approval typically takes 12-15 years and costs $100-800 million per drug.
This document discusses various topics related to pharmacovigilance including:
- Definitions of key terms like adverse drug reaction, adverse event, causality, and signal detection.
- International collaboration on pharmacovigilance through organizations like WHO and CIOMS.
- National and regional drug regulatory authorities like Health Canada, EMA, India's Pharmacovigilance Program, PMDA in Japan, and FDA in the US.
- Other topics covered include adverse event reporting, risk management, pharmacoenvironmentology, and pharmacovigilance of medical devices.
This document provides definitions and information related to pharmacovigilance. It discusses adverse event reporting, international collaboration, and national drug regulatory authorities. Key aspects of pharmacovigilance include collecting, monitoring, and preventing adverse effects of pharmaceutical products to assure their safe use.
This document provides an overview of clinical trials and their importance. It discusses the history of clinical trials dating back to the 1530s. Modern clinical trials aim to test whether treatments are safe and effective through a rigorous multi-phase process involving many participants. They are designed and reviewed carefully and help advance medical research for the benefit of patients and public health. Clinical trials follow strict protocols and require informed consent to ensure participant safety and data integrity.
Clinical Aspect of Drug Discovery and Development PCO 413.pptxCoutyNess
Clinical trials helps in the discovery and development of drugs which helps to improve health, drug discovery and development is a key aspect of medicine which ensure more improved drugs are been developed to improve health in the society
Postmarketing surveillance (PMS) involves monitoring the safety of pharmaceutical drugs and medical devices after they have been approved for public use. PMS is important because pre-approval clinical trials involve relatively small numbers of participants and may not detect rare or long-term adverse effects. PMS uses various methods like spontaneous reporting, cohort studies, and case-control studies to monitor drug and device safety in larger populations over longer time periods after approval. The goal of PMS is to further evaluate or confirm the safety profile of products as they are used in real-world clinical settings by more diverse patients than clinical trials.
During drug discovery, researchers first identify a biological target involved in a disease and validate it. They then work to identify a lead compound that interacts with the target. The lead compound is optimized for efficacy and safety through testing in cell and animal models. If successful, the drug progresses through three phases of clinical trials on human subjects to test its safety, effectiveness, and side effects. If clinical trials are successful, the FDA reviews the drug application and may approve the drug, allowing it to enter the market with ongoing monitoring and research.
Clinical trials have evolved since the 18th century to become a rigorous process for testing new medical treatments. There are typically four phases of clinical trials. Phase I trials test safety in small groups. Phase II explores efficacy. Phase III tests effectiveness against standard treatments in large groups. Phase IV monitors long-term safety post-approval. Clinical trials must include women, children, and pregnant women if a drug will be used to treat those populations, to determine safety under controlled conditions.
An introduction for those who may be interested in a career in clinical research, but need to understand the industry and their potential for a role in it.
Provides an overview of the later stages of drug development, explaining the phases of drug studies and explores in brief the key roles for those participating.
This document discusses tracking drugs across the supply chain in a regulated environment. It covers drug utilization reviews, compliance and persistence, concomitancy, dosing, and the lifetime value of patients. Drug utilization reviews help ensure appropriate medication decision making and outcomes. Tracking drugs and serializing packaging helps prevent counterfeiting and ensures drug safety. Associating adverse events and medications improves data quality in clinical trials.
SDTM Training for personnel with Junior and Intermediate level Clinical Trial Experience. Covers summary of most domains. Salient features include order of domain creation, importance of making programming Data/Metadata Driven, Nature of Clinical Raw Data, Summary of the Clinical Trial process with regards to the data flow to arrive at the Study data to be submitted to regulatory authorities like FDA, Importance of deriving ADAM from SDTM and not directly from raw data, Information has been put together from variety of sources including my own programming work.
The document summarizes regulatory affairs for the MHRA and USFDA. It discusses the history and roles of the MHRA in regulating clinical trials, licensing products, and enforcing regulations in the UK. It then outlines the development process for new drugs from discovery through licensing. Finally, it provides an introduction to the USFDA, covering its definition, history, mission, organization, functions, and products regulated.
Complementary and Alternative Medicine - 2 (Additional PLUS Reading Materials)Positive_Force
The document provides information for people considering complementary and alternative medicine (CAM) therapies. It advises readers to carefully research any CAM therapy's safety and effectiveness before use and discuss it with their healthcare providers. It also suggests choosing CAM practitioners and products carefully and being aware that "natural" doesn't always mean "safe". The document directs readers to reliable sources like the National Center for Complementary and Alternative Medicine for more information on specific CAM therapies.
This document provides an overview of the drug development process, which includes early drug discovery through preclinical research on animals, clinical trials with human subjects in four phases, regulatory review and approval, and post-marketing safety surveillance. The process aims to determine if a new drug is safe, effective for its intended use, and has the proper dosage before it can reach patients, and typically takes over a decade. Key steps include identifying drug targets, developing and screening candidate compounds, optimizing leads, conducting preclinical and clinical trials to test safety and efficacy, obtaining regulatory approval, and ongoing monitoring after approval.
This document provides an introduction to pharmacoepidemiology. It defines pharmacoepidemiology as the study of drug use and effects in large populations. It discusses study designs used in pharmacoepidemiology including randomized trials, cohort studies, case-control studies, and case reports. Reasons for performing pharmacoepidemiology studies include fulfilling regulatory and legal obligations, assessing drug safety, and generating or testing hypotheses. Common data sources are spontaneous adverse event reporting, prescription databases, and medical records. Issues like adherence, molecular factors, ethics, and economics are also discussed.
This document provides an introduction to pharmacoepidemiology. It defines pharmacoepidemiology as the study of drug use and effects in large populations. It discusses study designs used in pharmacoepidemiology including randomized trials, cohort studies, case-control studies, and case reports. Reasons for performing pharmacoepidemiology studies include fulfilling regulatory and legal obligations, assessing drug safety, and generating or testing hypotheses. Sources of data include spontaneous adverse event reporting, prescription databases, and electronic health records. The document also briefly discusses molecular pharmacoepidemiology, bioethics, pharmacoeconomics, and measuring quality of life outcomes.
1. Running head: PRE-EMPLOYMENT MEDICAL SCREENING
Final Paper
Pre-employment Medical Screening
Validity and Legality of Required Pre-employment Medical Testing
Katheryn C. Olcoz-Ferry
BUS 5070 B Human Resource
Warner University
Author Note
Katheryn Olcoz-Ferry, Department of Graduate Studies, Warner University. Correspondence
concerning this paper should be addressed to Katheryn Olcoz-Ferry, Department of Graduate
Studies, Warner University, Lake Wales, Fl. 33859.
Contact: katheryn.olcozferry@go.warner.edu
2. PRE-EMPLOYMENT MEDICAL SCREENING
Abstract
Employers have the option to screen employees for medical and illicit drug use before they are
hired. Many employers will not hire a candidate until all the results from the tests are back. Both
of these types of tests serve to ensure the safety of workplace, and all who come in contact with
the worker being tested (Pachman, 2009). The employer protects not only itself from harm done
by the afflicted employee but also protects its assets both tangible and nontangible. When an
employee is found to be taking illicit drugs on the job the negative publicity can damage both the
reputation of the business but can also cause irreparable harm to the organization by losing the
trust of the very people it promises to serve. Not only do the affects of illicit drugs have the
potential to harm employees but the infected employees who may transmit diseases are also
risking the health of fellow employees and others who come in contact with them. Therefore, isn’t
it in the best of everyone to test employees who may cause harm to themselves, the workers
around them, and the general public? Are these tests valid and legal? This paper will discuss these
points in an old light but will also attempt to answer some of new questions that are brought to
light.
Keywords: pre-employment medical screening, employment drug screen, drug testing
false positives, Hepatitis C.
2
3. PRE-EMPLOYMENT MEDICAL SCREENING
Validity and Legality of Required Medical Exam Pre-employment Medical Testing
History
It has been the standard protocol of many industries to perform pre-employment physicals.
Thirty years ago, many of these exams included a full exam by a physician who ran a series of
tests sometimes including x-rays and blood tests. In addition many organizations required
immunizations against certain diseases. Not much was done with the information that was
collected except to tell the prospective employee they needed more shots if their immunity was
lacking in certain antibodies. However, since the advent of computerized data bases, data
storage, and the availability of more testing such as routine drug screening along with the fact of
collection of medical information, it has become highly private causing a paradigm shift in how
and why tests are given (Pachman, 2009). It was thought back twenty or thirty years ago, an
employee received a free physical exam and no one seemed to mind, after all the data never went
anywhere.
Legal and Ethical Concerns
Privacy Issues. When AIDS entered the arena it impacted the workplace place just by
testing positive for the virus. It was a death sentence for anyone’s career, even though a cure was
found and ways to prevent the spread of the disease; it became a pariah of sorts to the world of
insurance and future employment. Nevertheless, testing continued and found its way into
businesses as a way to screen out illicit drug users and people who may be carrying infectious
diseases. When medical records went electronic, keeping them private became paramount to
protecting patients from the public domain. Evidence-based medicine is a fairly new concept
promoting sound medical practices and the use of protocols that ensure best medical testing and
data processing, as tools of medical information used in the health care industry (Pachman, 2009).
In clinical research data is collected to be used to help find cures and advance medicine, but when
3
4. PRE-EMPLOYMENT MEDICAL SCREENING
it is used in pre-employment testing is it used to determine if a candidate is fit for a job and has
become the “culture” to accept testing like this, according to Pachman, “There were few to no
validated criteria or research that would support their efficacy” (2009).
The American College of Occupational and Environmental Medicine's (ACOEM's)
Guidelines for Occupational and Environmental Health Programs and Practice highly recommends
pre-employment screening to target applicants who may endanger the safety of coworkers.
However, the screening should include a medical history and worker’s history. Each job has
different pressures and knowing the medical history and demands of the job will help determine if
the job description fits the job applicant (Mosher, et al, 2003).
Validity of Tests
Pre-employment testing can be discriminatory in many ways and some cases unlawful.
There are a plethora of tests used to screen applicants from testing for illicit drugs, alcohol,
psychological testing, and infectious diseases to mention just a few. One of most easily tested
areas is routine drug screen. Obviously no one wants someone who is “high on drugs” taking
care of patients or flying a jetliner. Therefore, it is an important consideration that these tests be
accurate and administered appropriately. The problem lies with the type of testing. One of the
testing kits can screen for 25 tests at one time. The following list demonstrates a kit that many
facilities use to screen applicants.
Figure 1.
Amphetamines AMP 1000 ng/mL Opiates OPI 300 ng/mL
Barbiturates BAR 300 ng/mL Oxycodone OXY 100 ng/mL
Benzodiazepines BZO 300 ng/mL Phencyclidine PCP 25 ng/mL
Buprenorphine BUP 10 ng/mL Propoxyphene PPX 300 ng/mL
4
5. PRE-EMPLOYMENT MEDICAL SCREENING
Cocaine COC 300 ng/mL THC THC 50 ng/mL
Ecstasy MDMA 500 ng/mL Tricyclic Antidepressants TCA 1000 ng/mL
Methadone MTD 300 ng/mL
Methamphetamine MET 1000 ng/mL
Source: Biorad (2014)
Figure 1. This chart depicts an example of an array of drugs that can be screened for illicit drugs.
Although these types of screening testing are utilized all the time it does not necessary mean the
candidate is taking illicit drugs. Many illicit drugs, such as the amphetamine group cross react
with many “amines”. Many medications are available in this country contain amphetamines
(Amphetamines, 2014). This list indicates just some of the drugs on the market for medical care.
Many of these drugs are prescribed as stimulants to treat all sorts of medical conditions such as
Attention Deficit Hyperactivity Disorder (ADHD), weight loss, and sinus issues.
List 1. Amphetamine based drugs
•Dexedrine – treatment of ADHD
•Adderall – treatment of narcolepsy and ADHD
•Dextroamphetamine – a medication used in the treatment of ADHD that is also sometimes
used to treat narcolepsy.
•Lisdexamfetamine – used in treatment of ADHD
•Methamphetamine
•Dextrostat - treatment of ADHD
•Ritalin – treatment of ADHD
Source: Amphetamines.com (2014)
This list shows drugs that could easily show up in testing for prospective employees.
There are a number of issues with routine drug screens in that it not only detects illicit drugs
such as methamphetamine, but it does not differentiate between illicit, prescribed and over the
counter drugs. In a professional setting, some providers are not even aware that there is
5
6. PRE-EMPLOYMENT MEDICAL SCREENING
generalized cross reactivity. Ideally, if a drug screen comes back positive for amphetamines,
confirmatory testing should be conducted which would rule out illicit drugs since they are much
more specific in their identification and can pin point exactly which drug was taken.
Therein lies the rub. When preparing for drug screen tests, many questions should be asked,
including “Are you taking anything other than food?” A woman may not realize that the over
counter diet supplement, phenylpropanolamine (Phenylpropanolamine, 2014) is a drug that
cross reacts with the amphetamine group being tested and therefore does not list it as a
medication being taken. Does this discriminate against girls in a certain age group? What about
the sinus sufferer who takes the over counter nasal spray containing the active ingredient, anti-
histamine, they too may not realize this drug cross reacts with the pre-employment drug screen.
Theoretically, the employer doing the hiring should send the sample in for identification and
confirmation where it can be determined exactly which over the counter drugs is cross-reacting.
What if employers do not confirm the tests? What if this candidate is turned away because the
screen is positive but another reason is given to avoid confrontation? These are a question that
must be asked. Many providers do not understand the validity of such screens and do not take
into account which test is positive and what might cross react. Too many times they assume if
a test is positive that person is “on drugs”.
In addition, psychological testing is perceived negative if someone is taking anti-
depressants, which easily show up in drug testing. Would they be discriminated against because
they even listed Prozac as a daily med? Although applicants are asked to list all of the
medications they are taking, just listing certain drugs taken may be perceived as an “unstable”
personality. This kind of information is taken in privacy and kept confidential, or is it.
Poppy seeds can test positive in certain drug screens, such as opiates. How does this affect
6
7. PRE-EMPLOYMENT MEDICAL SCREENING
an employment screen? If someone eats enough poppy seed in a desert, or on a MacDonald’s
hamburger bun could it cause a false positive opiates? It has happened. National Institute on
Drug Abuse (NIDA) had set the cut-off concentration level for opiate urine tests at 300 ng/ml
for the Federal Workplace Drug Testing Program. However, this level of testing was
misleading and giving false readings. Eating a poppy seed bun at a fast food restaurant will
cause blood levels to reach 250 ng/ml. Most drug screening tests do not differentiate illicit
opiates from innocuous ingestions of poppy seeds. It is even found that three teaspoons of
poppy seed can spike blood levels to over 1,000 ng/ml hours later (Winchester, 2014).
Legal Issues
While more businesses are held responsible to keep workers safe how far do employers go
to ensure the safety of their workers and the community they serve? Noe reminds us of the
WikiLeaks and Wall Street Insider trading probes have demonstrated how businesses must be
very careful with sensitive information and intellectual property (2014, p. 43). Medical testing
is dangerous in the wrong hands one only has to look back at the history of HIV testing and the
lives it destroyed just by testing someone, not to mention if the test came up positive.
Testing like this will likely influence human resource practices and many HR administrators may
want to curtail certain types of testing or fall prey to more litigation in relation to employee’s
rights to privacy. Employees have intellectual property rights and employers may not discuss
private information with anyone, this includes medical personnel (Noe, p.43)
Businesses must consider whether or not to perform pre-employment testing in this day
and age. There are many regulatory agencies, such as FMLA, ADA, Affirmative Action, and
EEO to name just a few, and rules that must be examined for the various risks that could violate
the rights of people (Noe, 2014). The question should be asked is, why is the organization
7
8. PRE-EMPLOYMENT MEDICAL SCREENING
testing and what tests are really pertinent. What will the results reveal and what do you do
with positive results? Is the testing performed because this is the way we have always done it?
Or is there a particular reason for wanting to know.
Another consideration for pre-employment testing is the validity of the tests. Are they
accurate? (Sunoo, 1997). Test kits used by clinical laboratories are time tested, quality
controlled and compared to other more sophisticated test kits. Are some employers using test
kits that have been validated? In addition what about the staff performing the tests? Are they
properly trained?
Purpose of Testing
Many hospital facilities both here and in Southwest England routinely screen for diseases
such as hepatitis, tuberculosis, and check to ensure a person’s immunity is high for measles
mumps and rubella. Both testing for the actual disease and also for immunity against disease
protects the employer and also the public whom they may have close contact. Southwest
England is now testing new recruits for HIV because of an incident where a worker had
contracted the HIV and patients were possibly put at risk, (Spooner, 2009).
Occupational injuries, employee accidents, and even death have resulted in employees
working while under the influence of drugs or alcohol. According to Kesselring & Pittman
there were 6500 deaths directly related to job injuries, 13.2 million injured workers, and
astounding more than 60,000 disease related deaths, and over 800,000 job related illnesses,
(2002). It is a no wonder that employers want to protect themselves from lawsuits, but also
they need to protect workers from other workers and the general public they may serve.
In 1987 then President Ronald Reagan enacted an Executive Order that required the executive
branch of the federal government to offer a “drug free workplace” (Kesselring & Pittman,
8
9. PRE-EMPLOYMENT MEDICAL SCREENING
2002). This action prompted many workplaces to implement their testing programs. Along
with economical and quick access to drug screen test kits testing for drugs became the norm.
What are the Costs?
Hepatitis C virus (HCV) infection is very prevalent in the United States. Three million
people, mostly under the age of 50 are affected and it is the leading cause of chronic liver
disease accounting for the most liver transplants (Alter, Seeff, Bacon, Thomas, 2004).
It stands to reason that hepatitis testing is routinely performed on new recruits. The tests will
indicate if the recruit has the disease or has had the disease and developed immunity. If you
have antibodies against the disease, it means either you exposed or had the disease and now
have immunity against the disease. This should be a good thing yet I question the efficacy of
such testing. Once the tests are performed the results become part of the electronic medical
record. Since there are privacy barriers, no one should see the results except the employer,
right? However, those records are open to insurance companies looking for history and any
reason not to insure a prospective client. Since Obama Care, having a previous medical
condition does not enter into the picture whether a candidate is picked up or not, however,
optional insurance such as long term care, or life insurance policies will question anyone with
Hepatitis C antibodies. They require further invasive testing which could label a candidate for
life. Shouldn’t this kind of testing be optional? If the candidate has no symptoms and has
never shown symptoms and carries the antibody around forever, should they be penalized and
labeled “not fit to be insured” forever, that in itself is staggering.
Emotional Costs
There is another issue that is not taken into consideration when a worker is testing for
these diseases. Life insurance policies and medical insurance both short term and long term
9
10. PRE-EMPLOYMENT MEDICAL SCREENING
care insurance companies will not insure anyone who is chronically infected with hepatitis C.
Even though the virus can lay dormant in the body for 30, 40 50 years and never cause any
symptoms. The statistics are difficult to come by but the outcome is nevertheless the same,
some insurance companies will not insure anyone with Hep C. Now consider the nurse who
has worked all her life to purchase a home but cannot secure life insurance to protect her
family. Or consider the worker who wants to save his family financial pain and suffering by
enrolling in long term care. These asymptomatic people have no recourse. The emotional cost
of not being able to get life insurance or long-term care insurance can be distressing.
Financial Costs.
For most employers, workmen compensation (WC) costs make up two to 10 percent of
payroll costs ((Rhodes & Rhodes, 2002). Most employers will strategize loss prevention and
control measures to cut down on the injury and accident rates. The goal is to reduce to insurance
claims and to manage injuries as they happen.
What is the cost of running these tests? Testing is performed at the expense of the
employer. The cost can be expensive because the tests are usually chain of custody type testing
and sent out to specialized laboratories. What is done with these new recruits that have tested
positive for diseases such as hepatitis? Organizations do not always notify the employee the
outcome of tests. This is because some places just do not understand the interpretation of the
testing. If an employer tests all new recruits this cost in the millions for a large company. The
cost to the workers is an ever-present privacy issue. When tests are run on urine samples, a
wealth of information can be obtained in addition to the drugs in question. These types of
samples contain all the ingredients produce information on a person that is unwarranted such as,
DNA, pregnancy, HIV, and other diseases.
10
11. PRE-EMPLOYMENT MEDICAL SCREENING
Workers who are tested for medical diseases are particularly vulnerable to breach of
privacy. Not only are drugs being screened, by the way only show if they are present and not in
what amount, but medical testing is performed that could cost hundreds of thousands of dollars
against the person being tested. What is the emotional cost of breach of privacy? It is
priceless.
Limitations of These Studies
This is just a short paper on a very intriguing subject. There really is no way of knowing
how many employees test positive for certain pre-employment tests or how many employers
neglect to communicate vital information medical to candidates. There are no statistics that I
could find that indicate how much is lost due to rejection by insurance companies or how many
people are rejected for employment due to testing positive for medications that should not have
influenced HRM in the first place.
Discussion
Employers are under tremendous pressure to hire the right person for the right job. Once
an recruit enters the domain of pre-employment testing some employers may assume that
allowing one recruit to fly under the radar by hiring in haste will cost them down the line by
higher accident rates, eventually experiencing a rise in worker’s compensation (WC) costs
(Rhodes & Rhodes, 2002). It is very difficult finding the candidates with the “right stuff” while
reducing costs and increasing production. However, as a manager is my duty investigate all
questionable results and to look at the whole person before coming to any conclusion. Pre-
11
12. PRE-EMPLOYMENT MEDICAL SCREENING
employment testing is vital to the security and safety of everyone. Testing for illicit drugs and
infectious diseases should be part of the hiring process. As technology advances so do methods
of testing and storing that data. As technology becomes more sophisticated so do the hackers
who feed off the data that is stored. As HRM becomes more “wired” it is easy to lose touch
with the people they serve. Noe points out; HRM in administration is decreasing as technology
is used for many administrative purposes (Noe, 2014). While this is a good strategy more
people need to be trained to interpret the data that is populating their screens. It cannot be left
up to the computer to differentiate a good hire from a bad hire just by collecting some tests.
These tests must be scrutinized along with the real person, in real time. Let us not forget to get
to know the people we are interviewing and to treat them with dignity and respect. Pre-
employment testing must be strategized, scrutinized, and validated before they are performed.
Each test needs to be revisited to qualify the reason they are being used and then the
implications of positives carefully thought out and studied to justify their very existence.
References:
Alter, M. J., Seeff, L. B., Bacon, B. R., Thomas, D. L., & al, e. (2004). Testing for
hepatitis C virus infection should be routine for persons at increased risk for infection. Annals of
Internal Medicine, 141(9), 715-7. Retrieved from
http://search.proquest.com/docview/222251283?accountid=35797
Amphetamines.com. (n.d.). Retrieved November 30, 2014, from
http://amphetamines.com/list-of-amphetamines/
Bio-Rad, TOX/See Rapid Urine Drug Screen Tests. (n.d.). Retrieved November 30, 2014,
from http://www.bio-rad.com/en-us/product/tox-see-rapid-urine-drug-screen-tests
12
13. PRE-EMPLOYMENT MEDICAL SCREENING
Kesselring, R. G., & Pittman, J. R. (2002). Drug testing laws and employment injuries.
Journal of Labor Research, 23(2), 293-301. Retrieved from
http://search.proquest.com/docview/214004562?accountid=35797
Minton-Eversole, T. (2010). Avoiding bias in pre-employment testing. HRMagazine,
55(12), 77-78,80. Retrieved from http://search.proquest.com/docview/815590613?
accountid=35797
Moshe, S., Slodownik, D., & Merkel, D. (2003). Value of preemployment medical
assessments for white-collar workers. Archives of Environmental Health, 58(11), 723-7.
Retrieved from http://search.proquest.com/docview/201275445?accountid=35797
Noe (2014-01-17). Human Resource Management. McGraw-Hill/Irwin. Kindle Edition.
Sunoo, B. P. (1997). Weighing the pros and cons of pre-employment testing. Workforce,
76(3), 125. Retrieved from http://search.proquest.com/docview/219767576?accountid=35797
Neal, K. R., Dornan, J., & Irving, W. L. (1997). Prevalence of hepatitis C antibodies
among healthcare workers of two teaching hospitals. who is at risk? British Medical Journal,
314(7075), 179-80. Retrieved from http://search.proquest.com/docview/203994514?
accountid=35797
Pachman, J. (2009, May 6). WHO Evidence base for pre-employment medical screening.
Retrieved November 29, 2014, from http://www.who.int/bulletin/volumes/87/7/08-052605/en/
Phenylpropanolamine, (2014), Wikipedia. Retrieved, November 29, 2014 from
http://en.wikipedia.org/wiki/Phenylpropanolamine
13
14. PRE-EMPLOYMENT MEDICAL SCREENING
Rhodes, D. P., & Rhodes, L. H. (2002). Best hiring practices aid accident prevention:
Fewer accidents lead to lower workers' compensation costs. Professional Safety, 47(10), 46-52.
Retrieved from http://search.proquest.com/docview/200387028?accountid=35797
Spooner, M. H. (2003). HIV testing now compulsory for new NHS staff. Canadian
Medical Association.Journal, 168(5), 600. Retrieved from
http://search.proquest.com/docview/205006267?accountid=35797
Winchester Hospital, True or false: eating poppy seed pastries can lead to a positive drug
test for heroin. (n.d.). Retrieved November 30, 2014, from
http://www.winchesterhospital.org/health-library/article?id=156998
14